Busmion, Romeo, JR.. M.
HRN: 00-13-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
CEFTRIAXONE 1G (VIAL)
02/01/2024
02/08/2024
IV
2 Grams
Once Daily
Multiple Soft Tissue Injury Secondary To MVA ( 2 Wheel, Driver, Collision); Rule Out Fracture, Right Leg
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes